Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
59 participants
OBSERVATIONAL
2019-01-01
2019-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Radiomics Multifactorial Biomarker for Pulmonary Nodules
NCT03872362
Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing
NCT03320044
Constructing a Predictive Model for Differentiating Between Benign and Malignant Solid Pulmonary Nodules Based on Clinical and Imaging Features.
NCT06685458
Early Adjuvant Diagnosis of Pulmonary Nodules Based on CTC.
NCT06187935
New Method to Differentiate Benign and Malignant Pulmonary Nodules.
NCT06056999
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with at least two nodules resected for pathological evaluation
Exclusion Criteria
* Presence of pneumonia or pleural effusion on thoracic CT scans
* Patients with none or only one nodule resected
* Patients with initial chemo-radiation therapy
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jun Wang
Chief,Thoracic Surgery Service
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jun Wang
Role: PRINCIPAL_INVESTIGATOR
Peking University People's Hospital
Yuqing Huang
Role: STUDY_DIRECTOR
Haidian Section of Peking University Third Hospital
Jiabao Liu
Role: STUDY_DIRECTOR
People's Hospital Affiliated to Hebei Medical University
Yingtai Chen
Role: STUDY_DIRECTOR
Beijing Aerospace 711 Hospital
Mingru Li
Role: STUDY_DIRECTOR
Beijing Aerospace 731 Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Peking University People's Hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PTHO1902
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.